Chronic Myeloid Leukemia

Dr. Michael Deininger -Chronic Myeloid Leukemia - CML

Chief, Division of Hematology and Hematologic Malignancies M.M. Wintrobe Professor of Medicine University of Utah Huntsman Cancer Institute ''Dr. Deininger's clinical interests center on leukemia, myeloproliferative neoplasms and hematopoietic stem cell transplantation. His research focuses on the biology of leukemia and development of molecularly targeted therapies for hematologic malignancies. The major focus of his lab is the molecular basis of resistance to tyrosine kinase inhibitors such as imatinib, a drug used to treat chronic myeloid leukemia and some other types of cancer. They are currently developing biomarker strategies to predict both response and resistance to tyrosine kinase inhibitor therapy.'' Extract of Huntsman Cancer Institute More info at University of Utah of medicine